Position
Creative Planning in Ocular Therapeutix, Inc
Back to the book · All holders of OCUL
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$89.2K$12.14 → $8.47
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 24.3K | $295.2K | — | — | — | 0.0% |
| Q1 2026 | 46.1K | $390.1K | $8.47 | −$89.2K | $184.1K | 0.0% |